Literature DB >> 21125263

Simultaneous analysis of buprenorphine, methadone, cocaine, opiates and nicotine metabolites in sweat by liquid chromatography tandem mass spectrometry.

Marta Concheiro1, Diaa M Shakleya, Marilyn A Huestis.   

Abstract

A liquid chromatography tandem mass spectrometry method for buprenorphine (BUP), norbuprenorphine (NBUP), methadone, 2-ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine (EDDP), cocaine, benzoylecgonine, ecgonine methyl ester (EME), morphine, codeine, 6-acetylmorphine, heroin, 6-acetylcodeine, cotinine, and trans-3'-hydroxycotinine quantification in sweat was developed and comprehensively validated. Sweat patches were mixed with 6 mL acetate buffer at pH 4.5, and supernatant extracted with Strata-XC-cartridges. Reverse-phase separation was achieved with a gradient mobile phase of 0.1% formic acid and acetonitrile in 15 min. Quantification was achieved by multiple reaction monitoring of two transitions per compound. The assay was a linear 1-1,000 ng/patch, except EME 5-1,000 ng/patch. Intra-, inter-day and total imprecision were <10.1%CV, analytical recovery 87.2-107.7%, extraction efficiency 35.3-160.9%, and process efficiency 25.5-91.7%. Ion suppression was detected for EME (-63.3%) and EDDP (-60.4%), and enhancement for NBUP (42.6%). Deuterated internal standards compensated for these effects. No carryover was detected, and all analytes were stable for 24 h at 22 °C, 72 h at 4 °C, and after three freeze/thaw cycles. The method was applied to weekly sweat patches from an opioid-dependent BUP-maintained pregnant woman; 75.0% of sweat patches were positive for BUP, 93.8% for cocaine, 37.5% for opiates, 6.3% for methadone and all for tobacco biomarkers. This method permits a fast and simultaneous quantification of 14 drugs and metabolites in sweat patches, with good selectivity and sensitivity.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21125263      PMCID: PMC3717346          DOI: 10.1007/s00216-010-4392-2

Source DB:  PubMed          Journal:  Anal Bioanal Chem        ISSN: 1618-2642            Impact factor:   4.142


  23 in total

Review 1.  Perspiration versus saliva--basic aspects concerning their use in roadside drug testing.

Authors:  G Skopp; L Pötsch
Journal:  Int J Legal Med       Date:  1999       Impact factor: 2.686

2.  Chemical composition of sweat.

Authors:  S ROBINSON; A H ROBINSON
Journal:  Physiol Rev       Date:  1954-04       Impact factor: 37.312

Review 3.  The role of alternative specimens in toxicological analysis.

Authors:  E Gallardo; J A Queiroz
Journal:  Biomed Chromatogr       Date:  2008-08       Impact factor: 1.902

4.  Acetylcodeine as a marker of illicit heroin abuse in oral fluid samples.

Authors:  S G Phillips; K R Allen
Journal:  J Anal Toxicol       Date:  2006 Jul-Aug       Impact factor: 3.367

5.  Disposition of cocaine and its metabolites in human sweat after controlled cocaine administration.

Authors:  Sherri L Kacinko; Allan J Barnes; Eugene W Schwilke; Edward J Cone; Eric T Moolchan; Marilyn A Huestis
Journal:  Clin Chem       Date:  2005-09-15       Impact factor: 8.327

6.  Opioid disposition in human sweat after controlled oral codeine administration.

Authors:  Eugene W Schwilke; Allan J Barnes; Sherri L Kacinko; Edward J Cone; Eric T Moolchan; Marilyn A Huestis
Journal:  Clin Chem       Date:  2006-06-01       Impact factor: 8.327

7.  Nicotine monitoring in sweat with a sweat patch.

Authors:  P Kintz; A Henrich; V Cirimele; B Ludes
Journal:  J Chromatogr B Biomed Sci Appl       Date:  1998-02-13

8.  Evaluation of acetylcodeine as a specific marker of illicit heroin in human hair.

Authors:  P Kintz; C Jamey; V Cirimele; R Brenneisen; B Ludes
Journal:  J Anal Toxicol       Date:  1998-10       Impact factor: 3.367

9.  Detection of drug use in a methadone maintenance clinic: sweat patches versus urine testing.

Authors:  J R Taylor; I D Watson; F J Tames; D Lowe
Journal:  Addiction       Date:  1998-06       Impact factor: 6.526

10.  Sweat testing in addicts under methadone treatment: an Italian experience.

Authors:  N Fucci; N De Giovanni; S Scarlata
Journal:  Forensic Sci Int       Date:  2007-04-10       Impact factor: 2.395

View more
  7 in total

1.  Quantitative mass spectrometry of unconventional human biological matrices.

Authors:  Ewelina P Dutkiewicz; Pawel L Urban
Journal:  Philos Trans A Math Phys Eng Sci       Date:  2016-10-28       Impact factor: 4.226

2.  Using sweat to measure cytokines in older adults compared to younger adults: A pilot study.

Authors:  Melissa D Hladek; Sarah L Szanton; Young-Eun Cho; Chen Lai; Caroline Sacko; Laken Roberts; Jessica Gill
Journal:  J Immunol Methods       Date:  2017-11-08       Impact factor: 2.303

3.  Preliminary buprenorphine sublingual tablet pharmacokinetic data in plasma, oral fluid, and sweat during treatment of opioid-dependent pregnant women.

Authors:  Marta Concheiro; Hendreé E Jones; Rolley E Johnson; Robin Choo; Marilyn A Huestis
Journal:  Ther Drug Monit       Date:  2011-10       Impact factor: 3.681

4.  High Coping Self-Efficacy Associated With Lower Sweat Inflammatory Cytokines in Adults: A Pilot Study.

Authors:  Melissa Hladek; Jessica Gill; Chen Lai; Kate Lorig; Sarah Szanton
Journal:  Biol Res Nurs       Date:  2019-09-05       Impact factor: 2.522

5.  Paper-Based Potentiometric Sensors for Nicotine Determination in Smokers' Sweat.

Authors:  Abd El-Galil E Amr; Ayman H Kamel; Abdulrahman A Almehizia; Ahmed Y A Sayed; Elsayed A Elsayed; Hisham S M Abd-Rabboh
Journal:  ACS Omega       Date:  2021-04-22

6.  A Preliminary Study of Biomonitoring for Bisphenol-A in Human Sweat.

Authors:  Christina A Porucznik; Kyley J Cox; Diana G Wilkins; David J Anderson; Nicole M Bailey; Kathryn M Szczotka; Joseph B Stanford
Journal:  J Anal Toxicol       Date:  2015-05-25       Impact factor: 3.220

7.  Evidence for the transfer of methadone and EDDP by sweat to children's hair.

Authors:  Hilke Andresen-Streichert; Justus Beike; Katharina Feld; Patrick Dahm; Tobias Kieliba; Axel Klee; Markus A Rothschild
Journal:  Int J Legal Med       Date:  2021-04-05       Impact factor: 2.686

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.